STOCK TITAN

Nutrien Financials

NTR
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Nutrien (NTR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 47 / 100
Financial Profile 47/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth
39

Nutrien's revenue grew a modest 3.5% year-over-year to $26.9B. This slow but positive growth earns a score of 39/100.

Leverage
100

Nutrien carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
22

Nutrien's current ratio of 1.34 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow
45

Nutrien has a free cash flow margin of 7.9%, earning a moderate score of 45/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
31

Nutrien's ROE of 9.1% shows moderate profitability relative to equity, earning a score of 31/100. This is up from 2.9% the prior year.

Piotroski F-Score Strong
7/9

Nutrien passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.74x

For every $1 of reported earnings, Nutrien generates $1.74 in operating cash flow ($4.0B OCF vs $2.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$26.9B
YoY+3.5%
5Y CAGR+5.2%

Nutrien generated $26.9B in revenue in fiscal year 2025. This represents an increase of 3.5% from the prior year.

EBITDA
N/A
Net Income
$2.3B
YoY+228.1%
5Y CAGR+38.0%

Nutrien reported $2.3B in net income in fiscal year 2025. This represents an increase of 228.1% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
$2.1B
YoY+40.7%
5Y CAGR+2.3%

Nutrien generated $2.1B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 40.7% from the prior year.

Cash & Debt
$701.0M
YoY-17.8%
5Y CAGR-13.6%

Nutrien held $701.0M in cash against $937.0M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
8.5%
YoY+5.8pp
5Y CAGR+6.3pp

Nutrien's net profit margin was 8.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.8 percentage points from the prior year.

Return on Equity
9.1%
YoY+6.2pp
5Y CAGR+7.0pp

Nutrien's ROE was 9.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 6.2 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$560.0M
YoY+194.7%
5Y CAGR+28.5%

Nutrien spent $560.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 194.7% from the prior year.

Capital Expenditures
$1.9B
YoY-7.1%
5Y CAGR+5.8%

Nutrien invested $1.9B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 7.1% from the prior year.

NTR Income Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

NTR Balance Sheet

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Total Assets $52.3B+0.9% $51.8B-1.7% $52.7B-3.4% $54.6B+9.3% $50.0B+5.9% $47.2B+0.8% $46.8B+2.9% $45.5B
Current Assets $14.7B+6.9% $13.8B-2.7% $14.2B-13.3% $16.3B+18.0% $13.8B+20.7% $11.5B+7.5% $10.7B-8.5% $11.7B
Cash & Equivalents $701.0M-17.8% $853.0M-9.4% $941.0M+4.4% $901.0M+80.6% $499.0M-65.7% $1.5B+116.7% $671.0M-71.0% $2.3B
Inventory $7.0B+13.5% $6.1B-3.0% $6.3B-17.0% $7.6B+20.6% $6.3B+28.4% $4.9B-0.9% $5.0B+1.2% $4.9B
Accounts Receivable $5.7B+5.3% $5.4B-0.1% $5.4B-12.9% $6.2B+15.4% $5.4B+48.0% $3.6B+2.4% $3.5B+6.0% $3.3B
Goodwill $12.1B+0.8% $12.0B-0.6% $12.1B-2.1% $12.4B+1.2% $12.2B+0.2% $12.2B+1.8% $12.0B+4.9% $11.4B
Total Liabilities $26.9B-1.7% $27.4B-0.5% $27.5B-4.1% $28.7B+9.4% $26.3B+5.9% $24.8B+3.6% $23.9B+13.5% $21.1B
Current Liabilities $11.0B-8.3% $12.0B-0.6% $12.1B-15.1% $14.3B+14.8% $12.4B+46.7% $8.5B-7.1% $9.1B+9.5% $8.3B
Long-Term Debt $937.0M-6.2% $999.0M0.0% $999.0M+11.1% $899.0M-3.7% $934.0M+4.8% $891.0M+3.7% $859.0M+7058.3% $12.0M
Total Equity $25.4B+3.8% $24.4B-3.0% $25.2B-2.6% $25.9B+9.1% $23.7B+5.8% $22.4B-2.2% $22.9B-6.2% $24.4B
Retained Earnings $12.1B+8.7% $11.1B-3.7% $11.5B-3.3% $11.9B+45.6% $8.2B+24.0% $6.6B-7.0% $7.1B-8.3% $7.7B

NTR Cash Flow Statement

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Operating Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

NTR Financial Ratios

Metric Q4'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q4'19 Q4'18
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 1.34+0.2 1.15-0.0 1.17+0.0 1.14+0.0 1.11-0.2 1.35+0.2 1.17-0.2 1.40
Debt-to-Equity 0.040.0 0.040.0 0.040.0 0.030.0 0.040.0 0.040.0 0.04+0.0 0.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Nutrien (NTR) reported $26.9B in total revenue for fiscal year 2025. This represents a 3.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Nutrien (NTR) revenue grew by 3.5% year-over-year, from $26.0B to $26.9B in fiscal year 2025.

Yes, Nutrien (NTR) reported a net income of $2.3B in fiscal year 2025, with a net profit margin of 8.5%.

As of fiscal year 2025, Nutrien (NTR) had $701.0M in cash and equivalents against $937.0M in long-term debt.

Nutrien (NTR) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Nutrien (NTR) has a return on equity of 9.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Nutrien (NTR) generated $2.1B in free cash flow during fiscal year 2025. This represents a 40.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Nutrien (NTR) generated $4.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Nutrien (NTR) had $52.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Nutrien (NTR) invested $1.9B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Nutrien (NTR) spent $560.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Nutrien (NTR) had a current ratio of 1.34 as of fiscal year 2025, which is considered adequate.

Nutrien (NTR) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Nutrien (NTR) had a return on assets of 4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Nutrien (NTR) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Nutrien (NTR) has an earnings quality ratio of 1.74x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Nutrien (NTR) scores 47 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top